Plain-English translation of NCT07563738 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Mesothelioma research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it works better when combined with existing cancer treatments for three types of advanced cancer: mesothelioma, pancreatic cancer, and non-small cell lung cancer. Researchers want to understand whether adding this medication to standard treatments that doctors already use can help patients live longer and feel better, while being safe to take.
Current cancer treatments help some patients, but many people's cancers still progress or return. This trial exists to find out whether adding this medication to proven treatments might improve how well they work and give patients more treatment options.
You likely qualify if…
You likely don't qualify if…
You would take as a daily pill along with your standard cancer treatment, which your doctor has already recommended for you. The study has two phases: first, doctors will test different doses of the medication to find the safest level, and then in the second phase, more patients will receive the dose that worked best. You'll visit the research clinic regularly for blood tests, scans, and checkups to see how you're doing and monitor any side effects.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States